Menu Close
PATHS-T1D Study — Leong Team
Human Studies / PATHS-T1D
Genetics · Recall-by-Genotype

Polygenic Assessment and Autoimmunity Testing for Health-System Screening of Type 1 Diabetes

This study uses a polygenic score to identify adults at increased genetic risk for type 1 diabetes and invites eligible participants for islet autoantibody screening, supporting earlier detection of presymptomatic autoimmune diabetes.

PATHS-T1D study
Study Design

Aims & What Participation Involves

Aims

  • Identify adults at increased genetic risk for type 1 diabetes using genetic data in the MGB Biobank.
  • Evaluate how clinical factors relate to islet autoantibody positivity within this genetically enriched group.

What Participation Involves

  • Review of existing biobank and health record data; no action needed unless contacted.
  • For eligible participants: islet autoantibody testing, using an archived sample where available or a new blood draw.
  • Participants with positive antibody results and no prior diabetes diagnosis may be invited for an oral glucose tolerance test visit.